A report is given of high incidence of vestibular and other reactions due to minocycline when used prophylactically for suspected meningococcal meningitis. Noncompliance and work loss due to the severity of the side effects should be strongly considered before minocycline is used for this indication.
Get full access to this article
View all access options for this article.
References
1.
Vestibular Reactions to Minocycline-Follow-Up, Georgia, New York, Vermont, Morbidity and Mortality24: No. 6: 55–56 (Feb.) 1975.
2.
Adverse Reactions of Minocycline, The Medical Letter17: No. 9 (Issue 425): 39–40 (Apr. 25) 1975.
3.
GuttlerRichard B.BeatyHarry N.: Minocycline in the Chemoprophylaxis of Meningococcal Disease, Antimicrobial Agents Chemotherapy1: 397–402 (May) 1972.
4.
McCormickJ. B.BennettJ. V., Public Health Considerations in the Management of Meningococcal Disease, Ann. Intern. Med.83: 883–886, 1975.
5.
GuttlerR. B.CountsG. W.AventC. K.: Effect of Rifampin and Minocycline on Meningococcal Carrier Rates, J. Infect. Dis.124: 199–205, 1971.
6.
EikhoffT. C.: In vitro and In vivo Studies of Resistance to Rifampin in Meningococci, J. Infect. Dis.123: 414–420, 1971.
7.
WeidmerC. E.DunkelT. B.PettyjohnF. S.: Effectiveness of Rifampin in Eradicating the Meningococcal Carrier State in a Relatively Closed Population: Emergence of Resistant Strains, J. Infect. Dis.124: 172–178, 1971.
8.
DealW. B.SandersE.: Efficacy of Rifampin in Treatment of Meningococcal Carriers, New Engl. J. Med.281: 641–645, 1969.
